Literature DB >> 15500876

Not-for-profit drugs--no longer an oxymoron?

David Sharp1.   

Abstract

Mesh：

Year:  2004        PMID： 15500876     DOI： 10.1016/S0140-6736(04)17291-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  [Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made].

Authors:  T Koch; V Wenzel
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

2.  Distributed Drug Discovery, Part 1: linking academia and combinatorial chemistry to find drug leads for developing world diseases.

Authors:  William L Scott; Martin J O'Donnell
Journal:  J Comb Chem       Date:  2009 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.